T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Zebra Technologies
ZBRA
$18B
| $51.8M | 0.01% |
202,160
-9,556
| -5% | -$2.47M |
|
652
Rentokil
RTO
$12.1B
| $51.3M | 0.01% |
+1,664,744
| New | +$51.7M |
|
653
Coca-Cola Consolidated
COKE
$12.7B
| $51.2M | 0.01% |
998,710
+3,570
| +0.4% | +$171K |
|
|
NARI
654
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $51M | 0.01% |
802,977
+139,929
| +21% | +$10.1M |
|
655
Deckers Outdoor
DECK
$12.7B
| $51M | 0.01% |
766,380
-130,530
| -15% | -$7.9M |
|
656
Fortune Brands Innovations
FBIN
$5.78B
| $50.9M | 0.01% |
891,435
+380,558
| +74% | +$20M |
|
657
Cytokinetics
CYTK
$10.2B
| $50.8M | 0.01% |
1,107,861
+14,414
| +1% | +$620K |
|
658
Builders FirstSource
BLDR
$7.91B
| $50.4M | 0.01% |
776,649
-180,997
| -19% | -$11.3M |
|
659
Watts Water Technologies
WTS
$12.8B
| $50.1M | 0.01% |
342,416
+2,000
| +0.6% | +$288K |
|
|
RXDX
660
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $50.1M | 0.01% |
455,059
+359,970
| +379% | +$23.3M |
|
661
Parker-Hannifin
PH
$134B
| $49.9M | 0.01% |
171,373
+1,318
| +0.8% | +$377K |
|
662
Cboe Global Markets
CBOE
$30.6B
| $49.8M | 0.01% |
396,540
+664
| +0.2% | +$81.9K |
|
663
Ryan Specialty Holdings
RYAN
$11B
| $49.4M | 0.01% |
1,191,114
+90,261
| +8% | +$3.69M |
|
664
Power Integrations
POWI
$3.48B
| $49.3M | 0.01% |
686,961
+123
| +0% | +$8.78K |
|
665
PTC Therapeutics
PTCT
$6.01B
| $49M | 0.01% |
1,284,389
-182,804
| -12% | -$7.6M |
|
666
Vail Resorts
MTN
$5.18B
| $49M | 0.01% |
205,540
+12,789
| +7% | +$3M |
|
667
Fortive
FTV
$18.7B
| $48.9M | 0.01% |
1,009,429
-1,519,373
| -60% | -$73.6M |
|
668
Procept Biorobotics
PRCT
$1.26B
| $48.5M | 0.01% |
1,168,617
+97,383
| +9% | +$4.18M |
|
669
EPAM Systems
EPAM
$5.24B
| $48.5M | 0.01% |
148,039
-2,341
| -2% | -$796K |
|
|
IAA
670
DELISTED
IAA, Inc. Common Stock
IAA
| $48.4M | 0.01% |
1,210,275
-32,228
| -3% | -$1.22M |
|
671
SM Energy
SM
$7.71B
| $48.2M | 0.01% |
1,385,102
+85,166
| +7% | +$3.54M |
|
672
Prudential Financial
PRU
$43B
| $48.2M | 0.01% |
484,685
-6,009
| -1% | -$609K |
|
673
Watsco Inc
WSO
$12.9B
| $47.5M | 0.01% |
190,328
-13,624
| -7% | -$3.58M |
|
|
DHR.PRB
674
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
| – | – |
0
| – | – |
|
675
iRhythm Holdings
IRTC
$4.06B
| $47.3M | 0.01% |
504,695
-187,883
| -27% | -$20.4M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.